Literature DB >> 24676960

Retinal venous pressure in the non-affected eye of patients with retinal vein occlusions.

Maneli Mozaffarieh1, M Bärtschi, P B Henrich, A Schoetzau, J Flammer.   

Abstract

BACKGROUND: To measure the retinal venous pressure (RVP) in both eyes of patients with unilateral central retinal vein occlusions and to compare these values to controls.
METHODS: The study included 31 patients with unilateral central retinal vein occlusions (CRVO) and 31 controls who were matched by age, sex, and systemic disease. RVP was measured in all patients bilaterally by means of contact lens ophthalmodynamometry, and the RVP measurements of the affected and unaffected eyes of patients were compared to the RVPs of controls. Ophthalmodynamometry is done by applying an increasing pressure on the eye via a contact lens. The minimum force required to induce a venous pulsation is called ophthalmodynamometric force (ODF). The RVP is defined and calculated as the sum of ODF and intraocular pressure (IOP) [RVP = ODF + IOP].
RESULTS: The RVP group means ± SD were as follows: patient's affected eyes (45.0 ± 11.6 mmHg), patient's unaffected eyes (38.0 ± 11.1 mmHg) ,and (17.7 ± 6.7 mmHg) in the eyes of controls. The values of RVP, even in the patients unaffected eyes, were significantly higher than in the eyes of controls (P < 0.001).
CONCLUSIONS: In patients with CRVO, the RVP is increased in both the affected as well as in the unaffected contralateral eye.

Entities:  

Mesh:

Year:  2014        PMID: 24676960     DOI: 10.1007/s00417-014-2617-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  21 in total

1.  Ozurdex in the management of the macular edema following retinal vein occlusion in clinical practice.

Authors:  Frederic Matonti; Franck Meyer; Sebastien Guigou; Tony Barthelemy; Stephane Dumas; Frederic Gobert; Christian Hajjar; Pierre Y Merite; Eric Parrat; Herve Rouhette; Stephan Pommier
Journal:  Acta Ophthalmol       Date:  2013-06-13       Impact factor: 3.761

2.  Endovascular cannulation with a microneedle for central retinal vein occlusion.

Authors:  Kazuaki Kadonosono; Shin Yamane; Akira Arakawa; Maiko Inoue; Tadashi Yamakawa; Eiichi Uchio; Yasuo Yanagi; Shiro Amano
Journal:  JAMA Ophthalmol       Date:  2013-06       Impact factor: 7.389

Review 3.  Endothelin-1 in peripheral arterial disease: a potential role in muscle damage.

Authors:  Janice C Tsui; Xu Shi-Wen
Journal:  Pharmacol Res       Date:  2011-03-05       Impact factor: 7.658

4.  Plasma endothelin-1 concentrations in patients with retinal vein occlusions.

Authors:  A Iannaccone; C Letizia; S Pazzaglia; E M Vingolo; G Clemente; M R Pannarale
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

5.  Intermittent hypoxia-induced increases in reactive oxygen species activate NFATc3 increasing endothelin-1 vasoconstrictor reactivity.

Authors:  J K Friedman; C H Nitta; K M Henderson; S J Codianni; L Sanchez; J M Ramiro-Diaz; T A Howard; W Giermakowska; N L Kanagy; L V Gonzalez Bosc
Journal:  Vascul Pharmacol       Date:  2013-11-15       Impact factor: 5.773

6.  Ophthalmodynamometric assessment of the central retinal vein collapse pressure in eyes with retinal vein stasis or occlusion.

Authors:  Jost B Jonas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-16       Impact factor: 3.117

7.  Intravitreal tenecteplase (metalyse) for acute management of retinal vein occlusions.

Authors:  Ian L McAllister; Sarojini Vijayasekaran; Dao-Yi Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-22       Impact factor: 4.799

8.  Optimizing the calibration and interpretation of dynamic ocular force measurements.

Authors:  William H Morgan; Stephen J Cringle; Min H Kang; Surinder Pandav; Chandrakumar Balaratnasingam; Don Ezekial; Dao-Yi Yu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-01-28       Impact factor: 3.117

9.  Retinal vein occlusions: The potential impact of a dysregulation of the retinal veins.

Authors:  Stephan A Fraenkl; Maneli Mozaffarieh; Josef Flammer
Journal:  EPMA J       Date:  2010-06-18       Impact factor: 6.543

Review 10.  The eye and the heart.

Authors:  Josef Flammer; Katarzyna Konieczka; Rosa M Bruno; Agostino Virdis; Andreas J Flammer; Stefano Taddei
Journal:  Eur Heart J       Date:  2013-02-10       Impact factor: 29.983

View more
  8 in total

1.  Retinal venous pressure is decreased after anti-VEGF therapy in patients with retinal vein occlusion-related macular edema.

Authors:  Teruyo Kida; Josef Flammer; Katarzyna Konieczka; Tsunehiko Ikeda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-15       Impact factor: 3.117

2.  Suppressed endothelin-1 by anti-VEGF therapy is important for patients with BRVO-related macular edema to improve their vision.

Authors:  Teruyo Kida; Josef Flammer; Hidehiro Oku; Seita Morishita; Masanori Fukumoto; Hiroyuki Suzuki; Katarzyna Konieczka; Tsunehiko Ikeda
Journal:  EPMA J       Date:  2016-08-24       Impact factor: 6.543

Review 3.  Diseases potentially related to Flammer syndrome.

Authors:  Katarzyna Konieczka; Carl Erb
Journal:  EPMA J       Date:  2017-09-13       Impact factor: 6.543

4.  Central Retinal Vein Occlusion in 2 Patients Using Antipsychotic Drugs.

Authors:  Koichiro Taki; Teruyo Kida; Masanori Fukumoto; Takaki Sato; Hidehiro Oku; Tsunehiko Ikeda
Journal:  Case Rep Ophthalmol       Date:  2017-07-26

5.  Retinal venous pressure measurements in patients with Flammer syndrome and metabolic syndrome.

Authors:  Dominique Mustur; Zakieh Vahedian; Jerome Bovet; Maneli Mozaffarieh
Journal:  EPMA J       Date:  2017-09-05       Impact factor: 6.543

Review 6.  Retinal venous pressure: the role of endothelin.

Authors:  Josef Flammer; Katarzyna Konieczka
Journal:  EPMA J       Date:  2015-10-26       Impact factor: 6.543

Review 7.  The discovery of the Flammer syndrome: a historical and personal perspective.

Authors:  Josef Flammer; Katarzyna Konieczka
Journal:  EPMA J       Date:  2017-05-22       Impact factor: 6.543

8.  Acupuncture benefits for Flammer syndrome in individuals with inherited diseases of the retina.

Authors:  Tilo Blechschmidt; Maike Krumsiek; Margarita G Todorova
Journal:  EPMA J       Date:  2017-05-31       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.